CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kidd, L. C. R.
Right arrow Articles by Tannenbaum, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kidd, L. C. R.
Right arrow Articles by Tannenbaum, S. R.
Cancer Epidemiology Biomarkers & Prevention Vol. 8, 439-445, May 1999
© 1999 American Association for Cancer Research

Urinary Excretion of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in White, African-American, and Asian-American Men in Los Angeles County1

La Creis R. Kidd, W. G. Stillwell, Mimi C. Yu, John S. Wishnok, Paul L. Skipper, Ronald K. Ross, Brian E. Henderson and Steven R. Tannenbaum2

Division of Bioengineering and Environmental Health [L. R. K., W. G. S., J. S. W., P. L. S., S. R. T.] and Department of Chemistry [S. R. T.], Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-307, and Kenneth Norris, Jr. Comprehensive Cancer Center, University of Southern California, Los Angeles, California 90033 [M. C. Y., R. K. R., B. E. H.]

Meats, such as beef, pork, poultry, and fish, cooked at high temperatures produce heterocyclic aromatic amines, which have been implicated indirectly as etiological agents involved in colorectal and other cancers in humans. This study examined the urinary excretion of a mutagenic/carcinogenic heterocyclic aromatic amine, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), among 45 African-American, 42 Asian-American (Chinese or Japanese), and 42 non-Hispanic white male residents of Los Angeles who consumed an unrestricted diet. Total PhIP (free and conjugated) was isolated from overnight urine collections, purified by immunoaffinity chromatography, and then quantified by high-pressure liquid chromatography combined with electrospray ionization mass spectrometry. Geometric mean levels of PhIP in Asian-Americans and African-Americans were approximately 2.8-fold higher than in whites. The urinary excretion levels of PhIP were not associated with intake frequencies of any cooked meat based on a self-administered dietary questionnaire, in contrast to our earlier finding (Ji et al., Cancer Epidemiol. Biomark. Prev., 3: 407–411, 1994) of a positive and statistically significant association between bacon intake and the urinary level of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) among this same group of study subjects. Although there is a statistically significant association between urinary levels of PhIP and MeIQx (2-sided P = 0.001), 10 subjects (8%) displayed extreme discordance between urinary PhIP and MeIQx levels. Several factors, including variable contents of heterocyclic aromatic amines in food, enzymic and interindividual metabolic differences, and analytical methodology determine the degree of concordance between the urinary excretion levels of PhIP and MeIQx. Accordingly, urinary excretion levels of a single heterocyclic aromatic amine can only serve as an approximate measure of another in estimating exposure to these compounds in humans consuming unrestricted diets.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. J. Turesky, J.-M. Yuan, R. Wang, S. Peterson, and M. C. Yu
Tobacco Smoking and Urinary Levels of 2-Amino-9H-Pyrido[2,3-b]Indole in Men of Shanghai, China
Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1554 - 1560.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Rodriguez, M. L. McCullough, A. M. Mondul, E. J. Jacobs, A. Chao, A. V. Patel, M. J. Thun, and E. E. Calle
Meat Consumption among Black and White Men and Risk of Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort.
Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 211 - 216.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Zhu, P. Chang, M. L. Bondy, A. A. Sahin, S. E. Singletary, S. Takahashi, T. Shirai, and D. Li
Detection of 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]-Pyridine-DNA Adducts in Normal Breast Tissues and Risk of Breast Cancer
Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 830 - 837.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. Goldman and P. G. Shields
Food Mutagens
J. Nutr., March 1, 2003; 133(3): 965S - 973.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. S. Hecht
Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer
Carcinogenesis, June 1, 2002; 23(6): 907 - 922.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W.G. Stillwell, R. Sinha, and S.R. Tannenbaum
Excretion of the N2-glucuronide conjugate of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in urine and its relationship to CYP1A2 and NAT2 activity levels in humans
Carcinogenesis, May 1, 2002; 23(5): 831 - 838.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. S. Kulp, M. G. Knize, M. A. Malfatti, C. P. Salmon, and J. S. Felton
Identification of urine metabolites of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine following consumption of a single cooked chicken meal in humans
Carcinogenesis, November 1, 2000; 21(11): 2065 - 2072.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W. Pfau
Correspondence re: L. R. Kidd et al., Urinary Excretion of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in White, African-American, and Asian-American Men in Los Angeles County. Cancer Epidemiol. Biomark. Prev., 8: 439-445, 1999
Cancer Epidemiol. Biomarkers Prev., May 1, 2000; 9(5): 533 - 534.
[Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. R. Kidd, W. G. Stillwell, M. C. Yu, J. S. Wishnok, P. L. Skipper, R. K. Ross, B. E. Henderson, and S. R. Tannenbaum
Reply
Cancer Epidemiol. Biomarkers Prev., May 1, 2000; 9(5): 534 - 534.
[Full Text]


Home page
Cancer Res.Home page
W. G. Stillwell, R. J. Turesky, R. Sinha, and S. R. Tannenbaum
N-Oxidative Metabolism of 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in Humans Excretion of the N2-Glucuronide Conjugate of 2-Hydroxyamino-MeIQx in Urine
Cancer Res., October 1, 1999; 59(20): 5154 - 5159.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1999 by the American Association for Cancer Research.